Icon

INSPRA (nda021437)- (25MG,50MG,100MG)

EPLERENONE UPJOHN
25MG,50MG,100MG
Yes No
2020-Oct-10 Expired
None None
None No
INSPRA is an aldosterone antagonist indicated for: • Improving survival of stable patients with symptomatic heart failure with reduced ejection fraction (HFrEF) after an acute myocardial infarction. • The treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. (
9 0 8
Total Other Developers 2
Drugs with Suitability No
25MG ** ** - - 5
50MG ** ** - - 5
100MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 6
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ******* ************ ******* *********** **** **. ** ** **, ******* ********** ******, *******, ******, *** ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. ***/***-****** / **** **.***/****-*********** , *******-***** ******* , ****** -******, ******, *********, ******* ******, ***** (***) ***
****** *********** ****** ********** - ***?***** ******?*****, *.*. *********** *** ** *****, *******, ****-***, ******** (***) ***
****** ************ *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** ****** ******* ************ ******* *********** *** ****-* **** **. *-**/*, *-***, & *-***, **** **. **, *** ********, ***** ******, *******-**********, ********* ******, ***** (***) ***
****** ******* ******* ********** ** ******* *********** ******* ****, *******, **************, ******* **** ***, ****** ******* (***) ***
****** ****** ****** ****** ****** ******* ******* *********** ****** **. ***, ******* *******, *********** ******,, **********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.